Originally from Barcelona, Dr. Oriol Parés i Grau studied medicine at Autònoma University of Barcelona (Vall d’Hebron Hospital) and University of Copenhagen (Rigshospitalet) and specialised in Radiation Oncology at Santa Creu i Sant Pau Hospital in Barcelona. At the end of the specialist training he received the Award for the best clinical case discussions by SCBO Catalano-Balear Society of Oncology in 2009. He won the Dr. Manuel Caralt Borrell “In Memoriam” Scholarship 2011-2012, and carried out post-graduated training on Stereotactic Body Radiotherapy and HDR-Brachytherapy at Mount Vernon Cancer Centre in London.
Dr. Parés was invited to join the Champalimaud Foundation in June 2012 becoming responsible for radiation oncology for the Digestive Unit and a member of the Prostate Unit. His interests focus on pelvic malignancies and concern about treatment-related toxicities, and he set a protocol for rectal cancer radiotherapy implementing State-of-the-Art technology with the aim of raising local responses and decreasing toxicity. Dr Parés is Principal investigator for the RECTBALL phase I study, with the aim of answering these questions. He is actively involved in radiosurgery protocols and hypofractionated radiotherapy schemes for rectal and prostate cancer, and is co-investigator in the Memorial Sloan-Kettering Cancer Center 10-154 study. Dr Parés is also a faculty member and lecturer in the Varian Medical Systems Advanced Techniques Clinical School.